South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

An announcement from AEON Biopharma ( ($AEON) ) is now available. On December 15, 2025, AEON Biopharma Inc. announced an Exchange Agreement with ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and ...

These companies could innovate their way to success.

One popular biotech ETF was up about 1% after the Federal Reserve announced its third interest-rate cut for the year. The Federal Reserve cut interest rates as expected - but for the biotech sector, ...

Applied’s lead candidate is a selective aldose reductase inhibitor called govorestat, an asset that failed to hit primary endpoints in late-stage trials for a progressive neuromuscular disease called ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...